Cognition Therapeutics, Inc.CGTXNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank40
3Y CAGR-23.0%
5Y CAGR+54.0%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-23.0%/yr
Annual compound
5Y CAGR
+54.0%/yr
Recent deceleration
Percentile
P40
Within normal range
vs 5Y Ago
8.7x
Strong expansion
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
2024$25.01M-16.4%
2023$29.92M-28.0%
2022$41.56M-24.0%
2021$54.72M+954.6%
2020$5.19M+79.6%
2019$2.89M-